Cargando…
Nivolumab-associated cutaneous T-cell lymphoma
Autores principales: | Marks, Jennifer A., Parker, Douglas C., Garrot, L. Crain, Lechowicz, Mary Jo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887609/ https://www.ncbi.nlm.nih.gov/pubmed/33644277 http://dx.doi.org/10.1016/j.jdcr.2020.12.033 |
Ejemplares similares
-
Induction of remission in a patient with end-stage cutaneous T-cell lymphoma by concurrent use of radiation therapy, gentian violet, and mogamulizumab
por: Westergaard, Sarah A., et al.
Publicado: (2020) -
Corneal ulceration associated with Nivolumab use
por: Parker, Jack S., et al.
Publicado: (2019) -
Clinical Remission of Cutaneous Squamous Cell Carcinoma of the Auricle with Cetuximab and Nivolumab
por: Chen, Alessandra, et al.
Publicado: (2018) -
Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
por: Oro-Ayude, Marcos, et al.
Publicado: (2020) -
Kaposi’s varicelliform eruption in a patient with metastatic melanoma and primary cutaneous anaplastic large cell lymphoma treated with talimogene laherparepvec and nivolumab
por: Miller, David M., et al.
Publicado: (2018)